Cook, J <br/><br/>
Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial.  [electronic resource] 

 -  AIDS research and human retroviruses  Apr 1999 
 - 499-508 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0889-2229 
<br/><br/><label>Standard No.: </label>10.1089/088922299311024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-HIV Agents--economics<br/>CD4 Lymphocyte Count<br/>Clinical Trials as Topic<br/>Cost-Benefit Analysis<br/>Costs and Cost Analysis<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--economics<br/>HIV-1--genetics<br/>Humans<br/>Indinavir--economics<br/>Lamivudine--economics<br/>Models, Biological<br/>Models, Economic<br/>Outcome and Process Assessment, Health Care<br/>RNA, Viral--blood<br/>Reverse Transcriptase Inhibitors--economics<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load<br/>Zidovudine--economics